Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1441 AL 1455

The efficacy of scopolamine for patients with Parkinson's disease and depression: Two case reports

Wang S, Guo P, Feng M, Qian M, Shen X, Wang G.

Asian J Psychiatr. 2020 Aug;52:102107. doi: 10.1016/j.ajp.2020.102107. Epub 2020 May 21.

Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson's Disease

Schneider A, Sari AT, Alhaddad H, Sari Y.

CNS Neurol Disord Drug Targets. 2020;19(3):195-206. doi: 10.2174/1871527319666200525011110.

Emerging 5-HT receptor antagonists for the treatment of Schizophrenia

Jones MT, Strassnig MT, Harvey PD.

Expert Opin Emerg Drugs. 2020 Jun;25(2):189-200. doi: 10.1080/14728214.2020.1773792. Epub 2020 Jun 8.

Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study

Cilia R, Bonvegna S, Straccia G, Andreasi NG, Elia AE, Romito LM, Devigili G, Cereda E, Eleopra R.

Mov Disord. 2020 Aug;35(8):1287-1292. doi: 10.1002/mds.28170. Epub 2020 Jun 11.

Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson's Disease?

Fabbri M, Zibetti M, Rizzone MG, Giannini G, Borellini L, Stefani A, Bove F, Bruno A, Calandra-Buonaura G, Modugno N, Piano C, Peppe A, Ardolino G, Romagnolo A, Artusi CA, Berchialla P, Montanaro E, Cortelli P, Luigi R, Eleopra R, Minafra B, Pacchetti C, Tufo T, Cogiamanian F, Lopiano L.

Mov Disord. 2020 Aug;35(8):1379-1387. doi: 10.1002/mds.28091. Epub 2020 May 25.

More than 20 years of the discovery of Park2

Mizuno Y.

Neurosci Res. 2020 Oct;159:3-8. doi: 10.1016/j.neures.2020.02.002. Epub 2020 May 23.

Nicotinamide riboside-A missing piece in the puzzle of exercise therapy for older adults?

Custodero C, Saini SK, Shin MJ, Jeon YK, Christou DD, McDermott MM, Leeuwenburgh C, Anton SD, Mankowski RT.

Exp Gerontol. 2020 Aug;137:110972. doi: 10.1016/j.exger.2020.110972. Epub 2020 May 22.

Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study

Ihle J, Artaud F, Bekadar S, Mangone G, Sambin S, Mariani LL, Bertrand H, Rascol O, Durif F, Derkinderen P, Scherzer C, Elbaz A, Corvol JC; DIGPD study group; Steering committee; Statistical analyses; Principal investigators for sites; Co-investigators (alphabetical order); Neuropsychologists; Genetic core; Sponsor activities and clinical research assistants.

Parkinsonism Relat Disord. 2020 Jun;75:30-33. doi: 10.1016/j.parkreldis.2020.03.017. Epub 2020 May 1.

The preclinical discovery and development of opicapone for the treatment of Parkinson's disease

Ettcheto M, Busquets O, Sánchez-Lopez E, Cano A, Manzine PR, Verdaguer E, Olloquequi J, Auladell C, Folch J, Camins A.

Expert Opin Drug Discov. 2020 Sep;15(9):993-1004. doi: 10.1080/17460441.2020.1767580. Epub 2020 May 26.

Stress and cortisol in Parkinson's disease

van Wamelen DJ, Wan YM, Ray Chaudhuri K, Jenner P.

Int Rev Neurobiol. 2020;152:131-156. doi: 10.1016/bs.irn.2020.01.005. Epub 2020 Feb 19.

The Role of Sphenobasilar Synchondrosis in Disease and Health

Liem T.

J Am Osteopath Assoc. 2020 Jun 1;120(6):404-412. doi: 10.7556/jaoa.2020.062.

Regulation of Iron Homeostasis and Related Diseases

Li Y, Huang X, Wang J, Huang R, Wan D.

Mediators Inflamm. 2020 May 2;2020:6062094. doi: 10.1155/2020/6062094. eCollection 2020.

The ubiquitous role of mitochondria in Parkinson and other neurodegenerative diseases

Theocharopoulou G.

AIMS Neurosci. 2020 Mar 25;7(1):43-65. doi: 10.3934/Neuroscience.2020004. eCollection 2020.

Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson's Disease

McCarty MF, Lerner A.

Int J Mol Sci. 2020 May 21;21(10):3624. doi: 10.3390/ijms21103624.

Anti-aggregation Effects of Phenolic Compounds on α-synuclein

Ono K, Tsuji M, Yamasaki TR, Pasinetti GM.

Molecules. 2020 May 24;25(10):2444. doi: 10.3390/molecules25102444.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias